IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 391 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,806,000,000 | +302843.7% | 178,875 | +222.3% | 0.07% | +188.0% |
| Q2 2019 | $3,567,000 | -78.4% | 55,500 | -72.7% | 0.02% | -78.6% |
| Q1 2019 | $16,504,000 | +19.4% | 203,325 | -20.5% | 0.12% | 0.0% |
| Q4 2018 | $13,820,000 | +7.3% | 255,650 | +2.4% | 0.12% | +27.2% |
| Q3 2018 | $12,874,000 | +30.6% | 249,600 | +5.6% | 0.09% | +17.9% |
| Q2 2018 | $9,854,000 | +10.5% | 236,475 | +16.9% | 0.08% | +13.0% |
| Q1 2018 | $8,917,000 | – | 202,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |